Compared to usual care, OSA therapy with continuous positiveairway pressure (CPAP) [35, 36, 37, 38, 39, 40] or implantation of a mandibular advancement device[41], improves insulin resistance without changing BMI, supporting a role fortissue hypoxia in the pathogenesis of insulin resistance. This evidence concerns the gene INS and obstructive sleep apnea syndrome.